Healthcare -
Biotechnology - NASDAQ - US
$ 0.5951
2.04 %
$ 174 M
Market Cap
-0.75
P/E
LYEL - GROSS PROFIT
Gross Profit LYEL - Lyell Immunopharma, Inc.
130 K
LAST VALUE
42.60%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR